bims-humivi Biomed News
on Human mito-nuclear genetic interplay
Issue of 2026–11–01
three papers selected by
Mariangela Santorsola, Università di Pavia



  1. Int J Mol Sci. 2026 Oct 11. pii: 9010. [Epub ahead of print]27(20):
      Mitochondrial genomes (mitogenomes) are no longer considered entities solely responsible for cellular bioenergetics, but as dynamic, multifaceted, and synchronized systems that integrate genome architecture, evolutionary processes, and organismal physiology. The present review summarizes the contemporary understanding of mitogenome organization and its diversity, evolution, and associated functions across eukaryotic life, with emphasis on mitonuclear co-evolution and relevance to human health. Moreover, the conserved and lineage-specific characteristics of mitogenome architecture, including its genetic content, topology, and regulatory elements, and their roles in governing the precise replication and transcription of the mitogenome are also comprehensively discussed. Additionally, the review explores the role of evolutionary dynamics, with emphasis on mutation-rate heterogeneity, recombination dynamics, gene rearrangements, and the interaction between mutation, natural selection, and genetic drift in shaping mitochondrial genome diversity and evolutionary trajectories. Comparative approaches have revealed extensive diversity in mitogenome structural organization and composition, which are closely associated with life-history traits of organisms, including metabolic rate, longevity, and reproductive characteristics. Notably, at the functional level, the variability potential of a mitogenome significantly influences oxidative phosphorylation efficiency, reactive oxygen species generation, and the orchestration of cellular signaling cascades. Fundamental to these processes is the existence of coordinated mitonuclear interrelationships, wherein coevolution between mitochondrial and nuclear-encoded genes safeguards bioenergetic functional integrity, whereas disruptions in this coordination may lead to reduced cellular fitness and progression of several diseases. Particularly in humans, mutations in mitochondrial DNA (mtDNA) and heteroplasmy significantly contribute to the development of primary mitochondrial disorders and are increasingly implicated in other complex disease etiologies, including neurodegeneration, metabolic syndromes, and cancer. The paper also summarizes the phylogenetic utility of mitogenomes in the genomic era, accentuating the need to employ integrative approaches that combine mitochondrial and nuclear data. Lastly, the role of emerging technological platforms, including long-read sequencing and multi-omics, is also discussed, since these approaches are expected to transform the current landscape of mitogenome research. Altogether, the manuscript positions mitogenomes as indispensable entities bridging the gaps between evolutionary histories, physiological functions, and personalized precision medicine.
    Keywords:  Dn/Ds; PCGs; bioenergetics; heteroplasmy; mitochondrial DNA; mitochondrial disease; mitochondrial evolution; mitogenome architecture; mitogenomes; mitonuclear coevolution; mtDNA; nDNA; nuclear DNA; phylogenomics; protein-coding genes; substitution rates for non-synonymous and synonymous mutations (substitutions)
    DOI:  https://doi.org/10.3390/ijms27209010
  2. Bioengineering (Basel). 2026 Sep 29. pii: 1139. [Epub ahead of print]13(10):
      Background: Carcinogenesis has traditionally been attributed to the accumulation of somatic mutations in nuclear genes regulating cell proliferation, survival, and apoptosis. Although hereditary genetic predispositions account for less than 10% of cases, the extensive heterogeneity of the somatic mechanisms driving tumorigenesis-including subsets of neoplasms lacking canonical nuclear mutations-suggests that non-mutational mechanisms and organelle dynamics significantly influence tumor onset. Emerging evidence increasingly supports the concept that mitochondrial dysfunction and metabolic reprogramming are essential factors in tumor development, rather than merely downstream consequences of nuclear genetic alterations. While current literature establishes mitochondrial alterations as crucial co-initiators and facilitators of early transformation, defining whether metabolic failures may eventually act as primary trigger remains an ongoing area of investigation. Within this perspective, the "Endosymbiotic/Evolutionary Theory" provides a useful heuristic model, since it conceptualizes metabolic rewiring not as a literal genetic reversal, but as an adaptive shift toward ancestral, highly glycolytic survival programs when oxidative microenvironments are compromised. Methods: We conducted a comprehensive theoretical and comparative analysis of mitochondrial biology, interrogating the structural, functional, and evolutionary parallels between mitochondria, intracellular bacteria, and viruses within the conceptual context of the endosymbiotic theory. Particular attention was given to mitochondrial proteins associated with organellogenesis, bioenergetic control, and molecular mechanisms facilitating mitochondrial-nuclear communication, including the integration of mitochondrial DNA (mtDNA) into nuclear DNA (nDNA) as nuclear mitochondrial DNA segments (NUMTs). Results: Under sustained bioenergetic stress, mitochondrial retrograde signaling can achieve regulatory dominance over the nucleus, driving a functional dissociation between organellar metabolic state and nuclear control. While not autonomous in a strict sense, this shift echoes the evolutionary legacy described by the endosymbiotic theory, whereby mitochondria act as semi-independent bioenergetic systems capable of imposing profound effects on nuclear gene expression and cellular fate. The resulting state is characterized by metabolic reconfiguration, loss of differentiation fidelity, and the acquisition of cancer stem cell-like properties. This process may unfold through a sequence of interrelated events: (1) persistent endogenous or exogenous stressors that challenge cellular homeostasis; (2) establishment of a chronic inflammatory state and sustained redox imbalance; (3) progressive disruption of the cellular microenvironment and inter-organelle communication; (4) emergence of a permissive pre-neoplastic niche characterized by impaired oxidative phosphorylation (OXPHOS), altered mitochondrial dynamics, and sustained retrograde signaling; (5) activation of adaptive survival pathways and escape from canonical cell death and checkpoint controls; and (6) progression toward a dedifferentiated, stem-like cellular phenotype associated with metabolic plasticity and increased resilience. Conclusions: We recommend that cancer be reframed as a dedifferentiated cellular state primarily driven by mitochondria-derived signaling, reflecting the organelle's ancestral autonomy and the reactivation of evolutionarily conserved mechanisms involving transposons, retrotransposons, Long Interspersed Nuclear Element-1 (L1), transposable elements (TEs), reactive oxygen species (ROS), and mtDNA-nDNA crosstalk, including the generation of nuclear mitochondrial DNA segments (NUMTs). This perspective extends the canonical view of predominantly nuclear-driven oncogenesis by reframing carcinogenesis as a bioenergetic and bio-evolutionary process, thereby highlighting mtDNA-nDNA interactions and mitochondrial signaling as central targets for cancer prevention, diagnosis, and therapy.
    Keywords:  L1; NUMTs; ROS; TERT; TEs; TIN2; TPP1; Telomere-Telomerase; cancer; differentiation; mitochondria; mtDNA; mtRNA; nDNA; oxidative phosphorylation (OXPHOS); retrotransposons; transposons
    DOI:  https://doi.org/10.3390/bioengineering13101139
  3. Rambam Maimonides Med J. 2026 Oct 26. 17(4):
      Mitochondrial replacement therapy (MRT) encompasses assisted reproductive technologies designed to prevent the transmission of pathogenic mitochondrial DNA (mtDNA) mutations by combining the DNA in the nucleus (nuclear genome) of the intending parents with another woman's enucleated egg that provides healthy donor-derived mtDNA. The use of advanced genomic engineering in MRT raises distinct ethical and halachic considerations regarding the ontological status of embryos containing genetic material from more than two individuals. This paper advances an original theoretical protocol, termed biparental mitochondrial replacement therapy (Bi-MRT), that mitigates the central halachic concerns associated with multi-parent embryos. In this protocol, future advances in stem cell technology could be employed to generate an enucleated gamete-like cell containing healthy mitochondria from the husband. The meiotic spindle-chromosome complex from the wife's oocyte could then be transplanted into this reconstituted gamete, which could be subsequently fertilized with the husband's sperm for IVF. If technically feasible and developmentally competent, the resulting embryo could potentially be transferred to the wife for gestation. By combining the wife's nuclear genetic contribution, gestation, and parturition with the husband's paternal DNA, this framework isolates the third-party mitochondrial contribution as a non-maternal factor, thereby reinforcing the wife's singular claim to halachic maternity. Biparental MRT therefore represents a theoretical framework that could potentially reduce some halachic concerns associated with conventional MRT, but substantial scientific and safety barriers remain before any clinical application could be contemplated.
    DOI:  https://doi.org/10.5041/RMMJ.10587